Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).

[1]  H. Sørensen,et al.  Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes , 2018, Journal of the American Heart Association.

[2]  R. Moreau,et al.  Acute-on-chronic liver failure: an update , 2017, Gut.

[3]  A. Keren,et al.  Serum Potassium Levels and Outcome in Patients With Chronic Heart Failure. , 2016, The American journal of cardiology.

[4]  Manuela Merli,et al.  Sarcopenia from mechanism to diagnosis and treatment in liver disease. , 2016, Journal of hepatology.

[5]  Richard Moreau,et al.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.

[6]  S. Kalko,et al.  Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis , 2016, Scientific Reports.

[7]  S. Sarin,et al.  Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis , 2016, Journal of gastroenterology and hepatology.

[8]  M. Epstein,et al.  Potassium homeostasis and dyskalemias: the respective roles of renal, extrarenal, and gut sensors in potassium handling. , 2016, Kidney international supplements.

[9]  R. Moreau,et al.  Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. , 2016, Journal of hepatology.

[10]  J. Dunn,et al.  The burden of hyperkalemia in patients with cardiovascular and renal disease. , 2015, The American journal of managed care.

[11]  C. Wingo,et al.  An Integrated View of Potassium Homeostasis. , 2015, The New England journal of medicine.

[12]  A. de Gottardi,et al.  Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis , 2015, Hepatology.

[13]  K. Thomopoulos,et al.  Impact of muscle wasting on survival in patients with liver cirrhosis. , 2015, World journal of gastroenterology.

[14]  D. S̆timac,et al.  Clinical profile, natural history, and predictors of mortality in patients with acute-on-chronic liver failure (ACLF) , 2015, Wiener klinische Wochenschrift.

[15]  A. Montano‐Loza,et al.  Clinical relevance of sarcopenia in patients with cirrhosis. , 2014, World journal of gastroenterology.

[16]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[17]  R. Hultcrantz,et al.  Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis , 2013, Scandinavian Journal of Gastroenterology.

[18]  P. Kamath,et al.  Acute-on chronic liver failure. , 2012, Journal of hepatology.

[19]  Y. Oh,et al.  Severe hyperkalemia requiring hospitalization: predictors of mortality , 2012, Critical Care.

[20]  G. Van den Berghe,et al.  Serum potassium levels and mortality in acute myocardial infarction. , 2012, JAMA.

[21]  J. Bosch,et al.  Management of varices and variceal hemorrhage in cirrhosis. , 2010, The New England journal of medicine.

[22]  D. Batlle,et al.  Acid-base and potassium disorders in liver disease. , 2006, Seminars in nephrology.

[23]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[24]  V. Arroyo,et al.  Management of cirrhosis and ascites. , 2004, The New England journal of medicine.

[25]  P. Cauchie,et al.  Potassium homeostasis in liver cirrhosis. , 1988, Archives of internal medicine.

[26]  R. Brown,et al.  Extrarenal potassium homeostasis. , 1986, Kidney international.

[27]  M. Davidman,et al.  Hyperkalemia provoked by acute hepatic necrosis. , 1986, American journal of nephrology.